ECSP055749A - FORMULATION OF SUSTAINED RELEASE TRAILER WITH EFFECTIVENESS OF 24 HOURS - Google Patents

FORMULATION OF SUSTAINED RELEASE TRAILER WITH EFFECTIVENESS OF 24 HOURS

Info

Publication number
ECSP055749A
ECSP055749A ECSP055749A ECSP055749A EC SP055749 A ECSP055749 A EC SP055749A EC SP055749 A ECSP055749 A EC SP055749A EC SP055749 A ECSP055749 A EC SP055749A
Authority
EC
Ecuador
Prior art keywords
hours
formulation
effectiveness
sustained release
release trailer
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Vincent Lenaerts
Patricia Laure Quadji-Njiki
Jonathan Bacon
Rachid Ouzerourou
Sonia Gervais
Miloud Rahmouni
Damon Smith
Original Assignee
Labopharm Inc
Labopharm Europe Ltd
Labopharm Barbados Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc, Labopharm Europe Ltd, Labopharm Barbados Ltd filed Critical Labopharm Inc
Publication of ECSP055749A publication Critical patent/ECSP055749A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporciona la administración oral de una formulación tramadol de liberación sostenida la cual, en la administración inicial de una dosis, proporciona un efecto analgésico dentro de 2 horas, cuyo efecto analgésico continúa por al menos 24 horas después de la administración.Oral administration of a sustained-release tramadol formulation is provided which, upon initial administration of a dose, provides an analgesic effect within 2 hours, the analgesic effect of which continues for at least 24 hours after administration.

ECSP055749 2002-10-25 2005-04-25 FORMULATION OF SUSTAINED RELEASE TRAILER WITH EFFECTIVENESS OF 24 HOURS ECSP055749A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28102602A 2002-10-25 2002-10-25
US51337803P 2003-10-10 2003-10-10

Publications (1)

Publication Number Publication Date
ECSP055749A true ECSP055749A (en) 2005-08-11

Family

ID=40202996

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP055749 ECSP055749A (en) 2002-10-25 2005-04-25 FORMULATION OF SUSTAINED RELEASE TRAILER WITH EFFECTIVENESS OF 24 HOURS

Country Status (1)

Country Link
EC (1) ECSP055749A (en)

Similar Documents

Publication Publication Date Title
UA84277C2 (en) Sustained-release tramadol formulations with 24-hour efficacy
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
EA200301165A1 (en) Drug on the basis of oxycodone
ECSP088422A (en) SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALINE
PT1506185E (en) NEW COMPOUNDS AND THEIR UTILIZATION
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
MXPA05007609A (en) CaSR ANTAGONIST.
PT1185253E (en) METHOD OF ORAL ADMINISTRATION FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
ATE541562T1 (en) IBUPROFEN SUSPENSION
BRPI0415053B8 (en) p-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
DE60302157D1 (en) OPIOID RECEPTOR ANTAGONISTS
ES2305567T3 (en) FORMULATIONS OF RELEASE OF SUSTAINED LIBERATION WITH EFFECTIVENESS OF 24 HOURS.
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
IS6087A (en) N- (2-phenyl-4-amino-butyl) -1-naphthamide which acts against neurotransmitter-1 receptors
TR200101245T2 (en) N-arylsulfonyl-amino-omega-amides
CY1112057T1 (en) THERAPEUTIC PRODUCTS FOR AUTOMATIC ADMINISTRATION
MXPA05008843A (en) Therapeutic system comprising amoxicillin and clavulanic acid.
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
UY28422A1 (en) EMULSIONING SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
AR039162A1 (en) VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION
ECSP055749A (en) FORMULATION OF SUSTAINED RELEASE TRAILER WITH EFFECTIVENESS OF 24 HOURS
EA200501565A1 (en) INTENDED FOR ORAL ADMINISTRATION MEDICINE FORM FOR PROTONE PUMP ANTAGONISTS
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments